La traduction de cette page est expérimentale et en cours de développement. N'hésitez pas à vos !

Clínica Las Condes Croissance future

Future contrôle des critères 0/6

Nous ne disposons actuellement pas d'une couverture d'analyste suffisante pour prévoir la croissance et les revenus de Clínica Las Condes.

Informations clés

n/a

Taux de croissance des bénéfices

n/a

Taux de croissance du BPA

Healthcare croissance des bénéfices	27.7%
Taux de croissance des recettes	n/a
Rendement futur des capitaux propres	n/a
Couverture par les analystes	None
Dernière mise à jour	n/a

Mises à jour récentes de la croissance future

Pas de mise à jour

Recent updates

Is Clínica Las Condes (SNSE:LAS CONDES) A Risky Investment?

Jul 02

Returns On Capital At Clínica Las Condes (SNSE:LAS CONDES) Paint A Concerning Picture

Apr 30

Clínica Las Condes S.A.'s (SNSE:LAS CONDES) Business Is Yet to Catch Up With Its Share Price

Mar 28

Returns On Capital At Clínica Las Condes (SNSE:LAS CONDES) Paint A Concerning Picture

Jan 12

Is Clínica Las Condes (SNSE:LAS CONDES) A Risky Investment?

Oct 24

Returns At Clínica Las Condes (SNSE:LAS CONDES) Are On The Way Up

Sep 27

Clínica Las Condes (SNSE:LAS CONDES) Is Experiencing Growth In Returns On Capital

Jun 21

Clínica Las Condes (SNSE:LAS CONDES) Takes On Some Risk With Its Use Of Debt

May 19

Clínica Las Condes (SNSE:LAS CONDES) Is Doing The Right Things To Multiply Its Share Price

Aug 25

There's Been No Shortage Of Growth Recently For Clínica Las Condes' (SNSE:LAS CONDES) Returns On Capital

Apr 20

Is Clínica Las Condes (SNSE:LAS CONDES) Using Too Much Debt?

Mar 10

There's Been No Shortage Of Growth Recently For Clínica Las Condes' (SNSE:LAS CONDES) Returns On Capital

Oct 07

A Look At The Fair Value Of Clínica Las Condes S.A. (SNSE:LAS CONDES)

Aug 28

Does Clínica Las Condes (SNSE:LAS CONDES) Have A Healthy Balance Sheet?

May 31

Some Investors May Be Worried About Clínica Las Condes' (SNSE:LAS CONDES) Returns On Capital

Apr 16

A Look At Clínica Las Condes' (SNSE:LAS CONDES) Share Price Returns

Mar 12

Clínica Las Condes (SNSE:LAS CONDES) Takes On Some Risk With Its Use Of Debt

Feb 05

Should You Be Impressed By Clínica Las Condes' (SNSE:LAS CONDES) Returns on Capital?

Jan 01

Clínica Las Condes'(SNSE:LAS CONDES) Share Price Is Down 36% Over The Past Five Years.

Nov 27

Dans cette section, nous présentons généralement des projections de croissance du chiffre d'affaires et des bénéfices basées sur les estimations consensuelles d'analystes professionnels afin d'aider les investisseurs à comprendre la capacité de l'entreprise à générer des bénéfices. Mais comme Clínica Las Condes n'a pas fourni suffisamment de données passées et n'a pas de prévisions d'analystes, ses bénéfices futurs ne peuvent pas être calculés de manière fiable en extrapolant les données passées ou en utilisant les prévisions des analystes.

Il s'agit d'une situation assez rare car 97% des entreprises couvertes par SimplyWall St disposent de données financières passées.

Prévisions de croissance des bénéfices et des revenus

SNSE:LAS CONDES - Estimations futures des analystes et données financières antérieures (CLP Millions )
Date	Recettes	Les revenus	Flux de trésorerie disponible	Cash from Op	Moy. Nombre d'analystes
6/30/2024	196,410	-2,977	2,729	5,996	N/A
3/31/2024	198,852	-2,146	8,110	12,433	N/A
12/31/2023	202,263	-3,401	7,991	13,589	N/A
9/30/2023	211,636	-3,614	10,542	18,272	N/A
6/30/2023	225,539	-1,240	26,211	35,639	N/A
3/31/2023	245,360	647	37,113	47,320	N/A
12/31/2022	259,992	4,047	37,205	49,213	N/A
9/30/2022	271,371	939	47,308	58,684	N/A
6/30/2022	279,943	8,916	36,052	46,376	N/A
3/31/2022	282,389	13,362	39,361	49,566	N/A
12/31/2021	276,854	18,417	29,900	37,601	N/A
9/30/2021	269,279	28,622	25,322	30,999	N/A
6/30/2021	248,857	19,437	18,136	22,066	N/A
3/31/2021	220,659	4,933	644	3,216	N/A
12/31/2020	212,266	-5,280	11,622	15,822	N/A
9/30/2020	202,808	-12,095	10,114	15,277	N/A
6/30/2020	209,306	-7,451	18,590	24,333	N/A
3/31/2020	224,860	1,750	22,405	29,031	N/A
12/31/2019	226,194	5,219	15,660	20,066	N/A
9/30/2019	227,965	8,375	25,815	29,195	N/A
6/30/2019	226,087	7,081	27,989	30,625	N/A
3/31/2019	224,119	4,778	13,992	16,806	N/A
12/31/2018	219,400	4,505	10,237	16,241	N/A
9/30/2018	206,418	-4,676	7,367	16,168	N/A
6/30/2018	203,297	-5,581	-4,785	8,939	N/A
3/31/2018	198,778	-5,100	N/A	24,030	N/A
12/31/2017	194,920	-10,346	N/A	25,341	N/A
9/30/2017	195,766	-9,252	N/A	21,246	N/A
6/30/2017	199,616	-5,559	N/A	8,245	N/A
3/31/2017	197,397	-3,258	N/A	3,253	N/A
12/31/2016	196,473	1,500	N/A	-7,191	N/A
9/30/2016	195,806	5,303	N/A	-20,704	N/A
6/30/2016	188,904	5,370	N/A	-4,569	N/A
3/31/2016	183,305	4,374	N/A	-5,973	N/A
12/31/2015	178,054	5,270	N/A	428	N/A
9/30/2015	174,007	7,929	N/A	9,025	N/A
6/30/2015	165,973	9,217	N/A	14,562	N/A
3/31/2015	160,604	12,272	N/A	15,747	N/A
12/31/2014	156,386	14,227	N/A	22,725	N/A
9/30/2014	151,772	17,275	N/A	24,894	N/A
6/30/2014	146,840	17,629	N/A	21,381	N/A
3/31/2014	142,837	18,135	N/A	23,327	N/A
12/31/2013	138,851	18,104	N/A	20,125	N/A
9/30/2013	136,462	17,669	N/A	20,475	N/A

Prévisions de croissance des analystes

Taux de revenus par rapport au taux d'épargne: Données insuffisantes pour déterminer si la croissance des bénéfices prévue de LAS CONDES est supérieure au taux d'épargne ( 5.5% ).

Bénéfices vs marché: Données insuffisantes pour déterminer si les bénéfices de LAS CONDES devraient croître plus rapidement que le marché CL

Croissance élevée des bénéfices: Données insuffisantes pour déterminer si les bénéfices de LAS CONDES devraient augmenter de manière significative au cours des 3 prochaines années.

Chiffre d'affaires vs marché: Données insuffisantes pour déterminer si les revenus de LAS CONDES devraient croître plus rapidement que le marché CL.

Croissance élevée des revenus: Données insuffisantes pour déterminer si les revenus de LAS CONDES devraient croître plus rapidement que 20% par an.

Prévisions de croissance du bénéfice par action

Rendement futur des capitaux propres

ROE futur: Données insuffisantes pour déterminer si le retour sur capitaux propres de LAS CONDES devrait être élevé dans 3 ans

Clínica Las Condes Croissance future

Future contrôle des critères 0/6

Informations clés

Mises à jour récentes de la croissance future

Recent updates

New major risk - Financial position

Second quarter 2024 earnings released: CL$5.00 loss per share (vs CL$94.00 profit in 2Q 2023)

Is Clínica Las Condes (SNSE:LAS CONDES) A Risky Investment?

Less than half of directors are independent

First quarter 2024 earnings released: EPS: CL$61.00 (vs CL$88.57 loss in 1Q 2023)

Returns On Capital At Clínica Las Condes (SNSE:LAS CONDES) Paint A Concerning Picture

Full year 2023 earnings released: CL$406 loss per share (vs CL$483 profit in FY 2022)

Clínica Las Condes S.A.'s (SNSE:LAS CONDES) Business Is Yet to Catch Up With Its Share Price

Now 22% overvalued after recent price rise

Now 22% overvalued after recent price rise

New major risk - Share price stability

Returns On Capital At Clínica Las Condes (SNSE:LAS CONDES) Paint A Concerning Picture

Third quarter 2023 earnings released: CL$419 loss per share (vs CL$136 loss in 3Q 2022)

Is Clínica Las Condes (SNSE:LAS CONDES) A Risky Investment?

Returns At Clínica Las Condes (SNSE:LAS CONDES) Are On The Way Up

New major risk - Financial position

Second quarter 2023 earnings released: EPS: CL$94.00 (vs CL$319 in 2Q 2022)

New major risk - Financial position

Clínica Las Condes (SNSE:LAS CONDES) Is Experiencing Growth In Returns On Capital

Investor sentiment improves as stock rises 17%

Clínica Las Condes (SNSE:LAS CONDES) Takes On Some Risk With Its Use Of Debt

Investor sentiment improves as stock rises 16%

Upcoming dividend of CL$145 per share at 1.3% yield

Investor sentiment improves as stock rises 21%

Full year 2022 earnings released: EPS: CL$483 (vs CL$2,199 in FY 2021)

Third quarter 2022 earnings released: CL$136 loss per share (vs CL$816 profit in 3Q 2021)

No independent directors

Investor sentiment improved over the past week

Investor sentiment improved over the past week

Second quarter 2022 earnings released: EPS: CL$319 (vs CL$850 in 2Q 2021)

Clínica Las Condes (SNSE:LAS CONDES) Is Doing The Right Things To Multiply Its Share Price

First quarter 2022 earnings released: EPS: CL$317 (vs CL$921 in 1Q 2021)

Upcoming dividend of CL$660 per share

No independent directors

There's Been No Shortage Of Growth Recently For Clínica Las Condes' (SNSE:LAS CONDES) Returns On Capital

Full year 2021 earnings released: EPS: CL$2,199 (vs CL$630 loss in FY 2020)

Is Clínica Las Condes (SNSE:LAS CONDES) Using Too Much Debt?

Third quarter 2021 earnings: Revenues and EPS in line with analyst expectations

There's Been No Shortage Of Growth Recently For Clínica Las Condes' (SNSE:LAS CONDES) Returns On Capital

Investor sentiment improved over the past week

A Look At The Fair Value Of Clínica Las Condes S.A. (SNSE:LAS CONDES)

Second quarter 2021 earnings released: EPS CL$850 (vs CL$882 loss in 2Q 2020)

Does Clínica Las Condes (SNSE:LAS CONDES) Have A Healthy Balance Sheet?

First quarter 2021 earnings released: EPS CL$921 (vs CL$298 loss in 1Q 2020)

Some Investors May Be Worried About Clínica Las Condes' (SNSE:LAS CONDES) Returns On Capital

A Look At Clínica Las Condes' (SNSE:LAS CONDES) Share Price Returns

Full year 2020 earnings released: CL$630 loss per share (vs CL$623 profit in FY 2019)

New 90-day low: CL$22,499

Clínica Las Condes (SNSE:LAS CONDES) Takes On Some Risk With Its Use Of Debt

New 90-day low: CL$23,820

Should You Be Impressed By Clínica Las Condes' (SNSE:LAS CONDES) Returns on Capital?

Third quarter 2020 earnings released: CL$281 loss per share

Clínica Las Condes'(SNSE:LAS CONDES) Share Price Is Down 36% Over The Past Five Years.

New 90-day low: CL$26,721

First half earnings released

Prévisions de croissance des bénéfices et des revenus

Prévisions de croissance des analystes

Prévisions de croissance du bénéfice par action

Rendement futur des capitaux propres

Découvrir les entreprises en croissance